Congenital Heart Disease

Congenital heart disease is the group of structural abnormalities of the heart and great vessels that are present at birth, arising from disturbed cardiac development. It is the most common group of major birth defects and, because affected children increasingly survive into adulthood, has become a leading chronic systemic condition originating in childhood.

Definition

Congenital heart disease comprises structural defects of the heart or intrathoracic great vessels present from birth - including septal defects, valve and outflow obstructions, and complex cyanotic malformations - that result from abnormal cardiac morphogenesis during embryonic development.

Scope

This entry covers congenital heart disease as a category: its origin in disrupted cardiogenesis, the broad physiological distinction between shunt and obstructive or cyanotic lesions, its birth prevalence and contributing risk factors, and the modern reality of long-term survival. It is a reference topic within pediatric chronic systemic disease and cross-links to the structural-heart-disease entry that treats the lesions from a cardiology perspective. It does not provide diagnostic or surgical guidance.

Core questions

• How do disturbances of embryonic heart development produce congenital cardiac defects?
• What broadly distinguishes shunt lesions from obstructive and cyanotic lesions?
• How common is congenital heart disease at birth, and what factors influence its occurrence?
• Why has congenital heart disease become a chronic condition extending into adulthood?

Key concepts

• Cardiac morphogenesis and looping
• Left-to-right shunt lesions
• Cyanotic heart disease
• Obstructive lesions
• Birth prevalence of defects
• Adults with congenital heart disease
• Genetic and noninherited risk factors

Mechanisms

Congenital heart defects arise when the highly orchestrated process of cardiac development - cardiac tube formation, looping, septation of the chambers and outflow tracts, and great-vessel patterning - is disrupted, producing structural abnormalities. The physiological consequences depend on the lesion: defects that connect the systemic and pulmonary circulations create shunts that can overload the lungs or, when blood bypasses the lungs, cause cyanosis, while obstructive lesions impede outflow. Both inherited genetic factors and noninherited maternal and environmental exposures contribute to the risk of these developmental disturbances (Jenkins et al., 2007).

Clinical relevance

Congenital heart disease is the commonest group of serious birth defects and a major source of infant morbidity, yet advances in diagnosis and surgery have shifted it toward a lifelong chronic condition with a growing adult population. Understanding the developmental origin and the broad physiological categories of lesions situates the condition within pediatric chronic disease. This entry describes the disease conceptually and is not a basis for individual clinical decisions.

Epidemiology

A systematic review and meta-analysis estimated a worldwide birth prevalence of congenital heart disease of roughly 8 per 1000 live births, with reported rates rising over time partly reflecting improved detection (van der Linde et al., 2011). Global Burden of Disease analyses document the substantial disability and mortality attributable to congenital anomalies, of which cardiac defects are a major component (James et al., 2018).

Evidence & guidelines

The birth-prevalence estimate summarised here is drawn from a systematic review and meta-analysis (van der Linde et al., 2011); the framing of inherited and noninherited risk factors follows an American Heart Association scientific statement (Jenkins et al., 2007); and population burden is tracked through Global Burden of Disease syntheses (James et al., 2018). Lesion-specific diagnostic and surgical management is governed by current cardiology and surgical guidance, which this reference entry does not reproduce.

History

Congenital heart disease was largely fatal in early life until the mid-twentieth century, when the advent of cardiac surgery - including the Blalock-Taussig shunt for cyanotic defects in the 1940s and later open-heart repair - transformed prognosis. Combined with prenatal and neonatal diagnosis, these advances converted many lethal malformations into survivable chronic conditions, creating the now-large population of adults living with congenital heart disease.

Seminal works

• van-der-linde-2011
• jenkins-2007

Frequently asked questions

How common is congenital heart disease?

A worldwide systematic review and meta-analysis estimated a birth prevalence of about 8 per 1000 live births, making it the most common group of major structural birth defects.

Why is congenital heart disease now considered a chronic condition?

Advances in diagnosis and cardiac surgery mean most affected children now survive into adulthood, so many require lifelong follow-up - creating a growing population of adults living with congenital heart disease.